Problem statement: Answer the MCQ question.
Query: Which drug exhibits a -7.609% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a. Cc1ccc(CSc2ccc(-c3ccc4c(c3)OCO4)nn2)cc1
b. Cc1cc(C)nc(-n2nc(C)c(Oc3ccccc3O)c2C)n1
c. C/C(=C\C=C\c1ccccc1)C(=O)c1c(C)cc(C)[nH]c1=O
d. CCCc1cc(=O)oc2cc(C)cc(OCC(=O)NCCCN3CCOCC3)c12
e. O=C(Nc1ccnn1C1CCN(C(=O)c2cccc(C(F)(F)F)c2)CC1)C1CC1
Answer: d. CCCc1cc(=O)oc2cc(C)cc(OCC(=O)NCCCN3CCOCC3)c12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCc1cc(=O)oc2cc(C)cc(OCC(=O)NCCCN3CCOCC3)c12
CCCc1cc(=O)oc2cc(C)cc(OCC(=O)NCCCN3CCOCC3)c12
2-(7-methyl-2-oxo-4-propylchromen-5-yl)oxy-N-(3-morpholin-4-ylpropyl)acetamide